Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Addex Therapeutics Ltd ADR
(NQ:
ADXN
)
8.110
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Addex Therapeutics Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For November 22, 2024
Today 3:32 EST
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 22, 2024
Via
Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
S&P 500 Edges Higher; American Woodmark Shares Slide
August 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
August 27, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Mixed; ScanSource Reports Weak Q4 Results
August 27, 2024
Via
Benzinga
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
August 27, 2024
Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330 million plus royalties under the...
Via
Benzinga
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 27, 2024
Via
Benzinga
After Disappointing Data, Johnson & Johnson Halts Developing Epilepsy Drug Candidate
July 22, 2024
Addex Therapeutics announces Janssen Pharmaceuticals, a Johnson & Johnson unit, has halted ADX71149 development for epilepsy after Phase 2 data.
Via
Benzinga
ADXN Stock Earnings: Addex Therapeutics Reported Results for Q1 2024
June 06, 2024
Addex Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 06, 2024
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!
Via
InvestorPlace
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 30, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 30, 2024
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!
Via
InvestorPlace
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 29, 2024
Via
Benzinga
Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher
April 29, 2024
Via
Benzinga
Exposures
Fossil Fuels
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
April 29, 2024
Latest Phase 2 epilepsy study findings on ADX71149 adjunctive therapy for focal onset seizures. Partnered with Janssen, Addex Therapeutics evaluates treatment efficacy in patients with suboptimal...
Via
Benzinga
Dow Surges Over 100 Points; Domino's Pizza Posts Upbeat Earnings
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!
Via
InvestorPlace
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
Earnings Scheduled For April 18, 2024
April 18, 2024
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
Via
Benzinga
ADXN Stock Earnings: Addex Therapeutics Reported Results for Q4 2023
April 18, 2024
Addex Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.